Aralez Bio
We have invented a novel enzymatic method for synthesizing noncanonical amino acids (ncAAs) also called unusual or unnatural amino acids. Our proprietary approach enables over 100 ncAAs to be synthesized with perfect enantiopurity in just a single step, with water as the only byproduct. To learn more, visit us at www.aralezbio.com Aralez Bio is a proud member of Cyclotron Road.
Aralez Bio
Aralez Bio is a San Francisco Bay Area-based company specializing in the enzyme-based production of noncanonical amino acids for pharmaceutical, biotech, and other industries.
About
Needs Assessment
Active buying signals and potential business opportunities
Technology Requirements
High-throughput screening equipment
Automation systems for amino acid synthesis
Molecular building blocks for tailored chemistry
Access to diverse libraries of noncanonical amino acids
Analytical equipment like HPLC and LCMS
Service Requirements
Custom synthesis of noncanonical amino acids to fit specific design constraints
Collaboration for specific needs
Rapid turnaround and on-time delivery of products
Superior service to customers and maintaining cooperative relationships with suppliers
Infrastructure Requirements
ISO 9001:2015 Manufacturing Facility
Fermentation capabilities for large-scale enzyme production
Scale-up of amino acid production to gram and kilogram scales
High-Density Fermentation to 10L
Talent Requirements
Protein engineers
Fermentation specialists
Biocatalysis experts
Scale-up specialists with experience in fermentation and biocatalysis
AI Insights
Growth Trajectory
With a recent $12MM funding round, Aralez Bio is positioned for significant growth by expanding its product catalog and scaling up production capabilities.
Market Opportunity
Aralez Bio's focus on sustainable and cost-efficient noncanonical amino acid production provides a strong competitive advantage in the growing market for bio-based products and pharmaceuticals.
Access Our Live VC Funding Database
30,000+ funded startups
tracked in the last 3 months
B2B verified emails
of key decision makers
Growth metrics
Real-time company performance data
Live updates
of new VC funding rounds
Advanced filters
for sophisticated queries
API access
with multiple export formats